
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
Author(s) -
Nahid Hatam,
Peivand Bastani,
Rahil Sadat Shahtaheri
Publication year - 2016
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.185725
Subject(s) - medicine , multiple sclerosis , quality of life (healthcare) , relapsing remitting , physical therapy , expanded disability status scale , disease , psychiatry , nursing
There is an increasing recognition among clinicians and researchers that the impact of chronic illnesses and their treatments must be assessed in terms of their quality of life (QoL) in addition to more traditional measures of clinical outcomes. The aim of this study was to compare the QoL in patients with relapsing-remitting multiple sclerosis (RRMS) using Avonex or CinnoVex.